Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells

Published:2016 Issue:3 Volume:19 Page:231
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Wang Shan¹²³,He Meifang⁴,Li Linmei¹²³,Liang Zhihua¹²³,Zou Zehong¹²³,Tao Ailin¹²³

Affiliation:

1. The State Key Clinical Specialty in Allergy, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

2. Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.

3. The State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.

4. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Funder

National Natural Science Foundation of China

Guangdong Provincial Public Welfare Research and Capacity Building Special Fundation

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

http://synapse.koreamed.org/pdf/10.4048/jbc.2016.19.3.231

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel hybrid benzoisothiazole-1,2,3-triazole-4-carboxamides with sub-micromolar toxicity towards human breast carcinoma cells and high affinity to DNA;Journal of Molecular Structure;2024-10

2. The Proapoptotic Action of Pyrrolidinedione–Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their Genotype;Cancers;2024-08-22

3. Tri-chalcone suppressed breast cancer cell proliferation and induced apoptosis through intrinsic and extrinsic pathways;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-14

4. Bruceantinol works as a CDK2/4/6 inhibitor to inhibit the growth of breast cancer cells;Chemico-Biological Interactions;2024-05

5. Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies;Marine Drugs;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3